aha semaglutide select trial 23 Late-Breaker Discussion: The Semaglutide lowers cardiovascular events even – Semaglutide Shows Secondary Cardiovascular Prevention

Some people notice a pronounced reduction in belly fat, while others experience changes in other areas first

The subcutaneous layer may be less uniform, with areas of tissue thinning alternating with areas of normal thickness

Roughly 1 in 8 (12%) consumers have taken a GLP-1 drug , per KFF, and that share is likely to rise: 26% of US consumers plan to take a weight loss drug to achieve their 2025 New Year's resolution goals , per Tebra

W., Williams, A

Importantly, pooled analyses from these trials did not demonstrate a statistically significant increase in pancreatic cancer incidence among GLP-1 users compared with placebo

That gas, when expelled as a burp, carries the distinctive rotten-egg smell